CRMAX | VEXAX | CRMAX / VEXAX | |
Total Expense Ratio | 1.21 | 0.05 | 2,420% |
Annual Report Gross Expense Ratio | 1.21 | 0.05 | 2,420% |
Fund Existence | 21 years | 25 years | - |
Gain YTD | -2.770 | 10.112 | -27% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 131M | 83.7B | 0% |
Annual Yield % from dividends | 0.29 | 1.10 | 26% |
Returns for 1 year | -14.85 | 11.65 | -127% |
Returns for 3 years | 4.70 | 58.64 | 8% |
Returns for 5 years | -3.29 | 52.04 | -6% |
Returns for 10 years | -20.98 | 152.21 | -14% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BSGPX | 13.90 | 0.12 | +0.87% |
Baillie Gifford Developed EAFE All Cap I | |||
ARYCX | 25.60 | 0.19 | +0.75% |
American Century Real Estate C | |||
JMCEX | 63.46 | 0.15 | +0.24% |
JPMorgan Mid Cap Equity R2 | |||
ELMCX | 19.66 | N/A | N/A |
Lord Abbett Emerging Markets Equity C | |||
FGFAX | 46.04 | -0.04 | -0.09% |
Federated Hermes International Leaders A |